Patents Assigned to Morphochem Aktiengesellschaft fü Kombinatorische Chemie
  • Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
    Patent number: 8513231
    Abstract: The present invention relates to the use of compounds, in which the pharmacophores of quinolone and oxazolidinone are chemically linked together through a linker that is stable under physiological conditions, for the treatment of anthrax and other infections.
    Type: Grant
    Filed: August 28, 2012
    Date of Patent: August 20, 2013
    Assignee: Morphochem Aktiengesellschaft fü Kombinatorische Chemie
    Inventors: Christian Hubschwerlen, Jean-Luc Specklin, Daniel Baeschlin, Hans Locher, Christine Schmitt